Check out the latest features and columns!

Pharmaceutical Executive January 2023

January's Executive Profile features Natalie Bickford, chief people officer at Sanofi

Enabling Authenticity

Pharm Exec's 18th Annual Pipeline Report focuses on spinal muscular atrophy, hemophilia A, intranasal and inhaled vaccines, gene-targeted therapy, and RNA therapeutics

Testing the Limits

Senior leaders focused on the advancement of digital medicine and health meet to discuss the importance of these tools for life sciences stakeholders

Whole-Person Care: Are We Ready? The Intersection of Pharma and Digital Therapeutics

Click for more information and to submit a nomination

Pharmaceutical Executive 2023 Emerging Pharma Leaders Awards

Dr. Arturo Loaiza-Bonilla, MD, is the co-founder and chief medical officer of Massive Bio.

Articles

Overcoming persistent barriers to health equity in oncology trials will require innovation and cooperation.

Health Equity Barriers in Oncology Trials

The platform is designed to reduce barriers to care for patients with COVID-19.

Pfizer and Ada Health Inc. To Launch Nationwide Online COVID-19 Care Journey

Jill Wechsler is Pharm Exec's Washington Corespondent

Proposed realignment of the Office of Regulatory Affairs would impact oversight of drugs and medical devices as well.

FDA Food Center Reorganization Puts Field Inspections in Limbo

 and can be reached at mrivers@mjhlifesciences.com.

Podcasts

Piper Trelstad, PhD, head of CMC, Bill & Melinda Gates Medical Research Institute, shares her experience being a woman in pharma, particularly at the C-suite level, as well as how to have more diversity in the industry.

Working in a Male-Dominated Field

Lisa Henderson is the group editorial director of 

 and can be reached at lhenderson@mjhlifesciences.com.

Pharm Exec details the career of Rajesh K. Rajpal, MD, the chief medical officer and global head of clinical and medical affairs at J&J Vision.

The Circle of Vision

Face-to-face meetings will now include in-person and virtual components.

FDA Resumes In-Person Meetings with Industry…Sort Of

Amgen Lays Off 300 Employees, "Mainly Its Commercial Team"

Sysnav Healthcare and Roche enter a partnership to facilitate development of industry standard outcome measurements in diseases associated with movement impairments, as well as designing the next generation of wearable technology based on Sysnav's technology.

Sysnav Healthcare Announces a Multi-Year Collaboration with Roche

 and can be reached at fpollaro@mjhlifesciences.com.

What’s changing in post-pandemic HCP access? Veeva’s vice president of global business consulting unveils the latest data.

Post-Pandemic HCP Access: Q&A with Dan Rizzo, Vice President of Veeva Global Business Consulting

A Q&A with Bridget Seay, epocrates’ executive director of customer experience & commercial consulting.

Featured Content

Pharmaceutical Executive January 2023

Enabling Authenticity

Testing the Limits

Whole-Person Care: Are We Ready? The Intersection of Pharma and Digital Therapeutics

Pharmaceutical Executive 2023 Emerging Pharma Leaders Awards